Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus structural proteins are components of the rotavirus virion essential for its architecture, infectivity, and replicative cycle. The major structural proteins include VP1 (RNA-dependent RNA polymerase), VP2 (core shell), VP3 (guanylyltransferase/methyltransferase), VP4 (spike protein mediating cell attachment/entry), VP6 (forms the intermediate capsid layer), and VP7 (outer capsid glycoprotein). These proteins form three concentric layers that encapsulate the virus's 11-segment double-stranded RNA genome. VP4 and VP7 are the main antigens recognized by neutralizing antibodies, making them targets for current vaccines, and the VP6 protein is commonly used as a biomarker for laboratory diagnosis. The collective term "rotavirus structural proteins" is a functional grouping; each protein has a distinct sequence, role, and relevance in infection, diagnostics, or immunology. There are currently no direct small-molecule therapeutics targeting these proteins; intervention is mainly via vaccine-elicited immunity.
Neutralizing antibody: blocks viral attachment or penetration (for VP4, VP7); Vaccine-mediated immunity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus structural proteins (VP).